Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome

By Kazerooni T.   Dehghan-Kooshkghazi M.  

Gynecological Endocrinology, Vol. 17, Iss. 1, 2003-02 ,pp. : 51-56

Informa Healthcare

Access to resources Recommend Favorite

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

By Cibula D.  

Human Reproduction, Vol. 16, Iss. 5, 2001-05 ,pp. : 940-944

Oxford University Press

Access to resources Recommend Favorite

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol–cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

By Elter Koray   Imir Gonca   Durmusoglu Fatih  

Human Reproduction, Vol. 17, Iss. 7, 2002-07 ,pp. : 1729-1737

Oxford University Press

Access to resources Recommend Favorite

The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin

By Vaikkakara Suresh   Al-Ozairi Ebaa   Lim EeLin   Advani Andrew   Ball Stephen   James R. Andrew   Quinton Richard  

Gynecological Endocrinology, Vol. 24, Iss. 2, 2008-01 ,pp. : 87-92

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome

By Vural Birol  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2409-2413

Oxford University Press

Access to resources Recommend Favorite